Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

20-year-old Katie loves tutorial porn. The university student, who is using her first name only for privacy reasons, tells Mashable that it helped her to understand sex during a time where it ...

(Reuters) - The 1st U.S. Circuit Court of Appeals said a Keryx Biopharmaceuticals Inc investor cannot revive his lawsuit alleging the Boston-based pharmaceutical company hid supply chain issues. Keryx ...

CAMBRIDGE, Mass. & BOSTON--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq:AKBA) and Keryx Biopharmaceuticals, Inc. today announced the successful completion of their previously announced merger.

Please provide your email address to receive an email when new articles are posted on . Akebia Therapeutics Inc. and Keryx Biopharmaceuticals Inc. have approved a definitive merger agreement under ...

Akebia Therapeutics Inc. and Keryx Biopharmaceuticals Inc. said Thursday they have agreed to merge in an all-stock deal that will create a company focused on chronic kidney disease. The companies said ...

Akebia Therapeutics is set to merge with Keryx Biopharmaceuticals. The combined company will own potentially complementary kidney disease drugs and a sales force to promote them, setting it up to fend ...

CAMBRIDGE, Mass. & BOSTON--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA) and Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that the companies signed, and the boards of ...

The chief executive of Keryx Biopharmaceuticals Inc., Gregory P. Madison, has resigned, the company said Monday, but did not provide a specific reason for his departure. Madison, who also gave up his ...

Keryx’s Auryxia has so far struggled to get off the ground. But after winning its second FDA approval, the company’s now prepping for a launch that it thinks can take the drug to the next level.

Keryx Biopharmaceuticals Inc.KERX is a Boston-based biopharmaceutical company working in the field of renal diseases. The company's only marketed product, Auryxia (ferric citrate) was approved in the ...